aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Orphion Therapeutics, a pioneering gene therapy developer, is dedicated to creating innovative treatments for rare and serious genetic disorders. The company was founded by an experienced executive management team with a strong background in drug development. Orphion's core mission is to advance gene therapy solutions that can significantly improve the lives of patients suffering from these debilitating conditions. Their market focus is on addressing unmet medical needs within the realm of rare genetic diseases.
The company is supported by a network of respected healthcare investors, which underscores its credibility and potential in the biotech industry. Orphion Therapeutics has made notable strides in the field of gene therapy, leveraging cutting-edge technologies and research to develop their treatments. The impact of their work is profound, offering hope and potential cures for conditions that currently have limited or no treatment options.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Gene Therapy
Technology
Biotech
Tags
Biotech
Model Types
Licensing, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Americas
When was Orphion Therapeutics founded?
Orphion Therapeutics was founded in 2020.
Where is Orphion Therapeutics’s headquarters located?
Orphion Therapeutics’s headquarters is located in Great Neck, NY, US.
When was Orphion Therapeutics’s last funding round?
Orphion Therapeutics’s most recent funding round was for $5.3M (USD) in November 2020.
How many employees does Orphion Therapeutics have?
Orphion Therapeutics has 6 employees as of Feb 5, 2024.
How much has Orphion Therapeutics raised to-date?
As of July 05, 2023, Orphion Therapeutics has raised a total of $5.3M (USD) since Nov 17, 2020.
Add Comparison
Total Raised to Date
$5.3M
USD
Last Update Nov 17, 2020
Last Deal Details
$5.3M
USD
Nov 17, 2020
Series Unknown
Total Employees Over Time
6
As of Feb 2024
Orphion Therapeutics Address
57 Meadow Woods Road
Great Neck,
New York
11020
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts